CLOSE X

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE3013.6533.6 (+1.13 %)
PREV CLOSE ( ) 2980.05
OPEN PRICE ( ) 2998.80
BID PRICE (QTY) 3007.05 (1)
OFFER PRICE (QTY) 3013.50 (58)
VOLUME 4584
TODAY'S LOW / HIGH ( )2998.80 3048.90
52 WK LOW / HIGH ( )2088 3051
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
R S Karnad - Chairman Bhushan Akshikar - Managing Director
Registered Office

Address 252, Gsk House,Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com / in.investorquery@gsk.com

Website www.gsk-india.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
21Jul GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulations 29 & 33 of the Listing Obligations and Discl..
25Jun GlaxoSmithKline Pharmaceuticals infor
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
08Jun GlaxoSmithKline Pharmaceuticals inf
In terms of the requirements of Regulation 36(1)(b) of the SEBI (Listing..
26May GlaxoSmithKline Pharmaceuticals infor
In compliance with the provisions of Regulation 24A of SEBI LODR Amendme..
21Apr GlaxoSmithKline Pharmaceuticals inform
In compliance with Regulation 30 of Securities and Exchange Board of Ind..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit2533.310118.2
Gross Profit 3379.8 13762.3
Operating Profit 3547.914427.6
Net Sales 9244.237902
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 23300.00 (1.50%)
M.Cap ( in Cr)29875.42
Divi's Laboratories (BSE)
 8905.50 (2.60%)
M.Cap ( in Cr)236267.04
Bharat Parenterals (BSE)
 1589.00 (7.33%)
M.Cap ( in Cr)1020.01
Fredun Pharma (BSE)
 1506.00 (3.89%)
M.Cap ( in Cr)2496.59
NGL Fine-Chem (BSE)
 2857.20 (1.77%)
M.Cap ( in Cr)1773.09
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.41%
MUTUAL FUNDS/UTI 4.87%
FI/BANKS/INSURANCE 2.79%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data July 2026 Broking Complaints Data July 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.